1 / 4

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals

This report studies the Asia-Pacific nuclear medicine market over the forecast period of 2012-2017.The Asia-Pacific radiopharmaceutical market was valued at $500.8 million in 2012 and is poised to reach $824.9 million by 2017 at a CAGR of 10.5%.Similar to the global nuclear medicine market, the Asia-Pacific region is also minimizing its dependency on nuclear reactor by introducing hospital-based cyclotron facilities. This paves the way for novel isotopes such as Tl-201, F-18, and Rb-82 to capitalize on opportunities in the growing diagnostics market. Besides the gigantic Tc-99m market, florbetapir F 18 and F18-FDG are gaining popularity through their applications for Alzheimer

david76
Download Presentation

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Markets and Markets Asia Pacific Nuclear medicine & Stable isotopes Market ( 2017) http://www.marketsandmarkets.com/Market-Reports/asia-pacific-nuclear-medicine-radiopharmaceuticals-market-1140.html

  2. INTRODUCTION • The market research report “Marketsandmarkets adds a new report“Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market & Stable Isotopes [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017”has been published by MarketsandMarkets. According to this report, It illustrates that The Asia-Pacific radiopharmaceutical market was valued at $500.8 million in 2012 and is poised to reach $824.9 million by 2017 at a CAGR of 10.5%. • . • Browse >> • Browse 146 market data tables with 27 figures spread through 313 pages and in-depth TOC on Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market • http://www.marketsandmarkets.com/Market-Reports/asia-pacific-nuclear-medicine-radiopharmaceuticals-market-1140.html • Request to Download Free PDF Brochure @

  3. Scope of Report • The radioisotope and stable isotope markets have been segmented according to the type of isotope, and applications. Both these markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by country (Japan, China, India, South Korea, Malaysia, Indonesia, Australia, New Zealand, and Rest of Asia) to provide in-depth information on the Asia-Pacific scenario.

  4. About Marketsandmarkets: MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Get in touch with us at +1-888-6006-441 or send email to sales@marketsandmarkets.com with your contact details and questions if any query.

More Related